As of 2024-12-11, the Relative Valuation of Calliditas Therapeutics AB (CALTX.ST) is (116.81) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 208.00 SEK, the upside of Calliditas Therapeutics AB based on Relative Valuation is -156.2%.
The range of the Relative Valuation is (93.76) - (125.02) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 15.6x | 12.4x |
| Forward P/E multiples | 11.7x - 21.9x | 16.8x |
| Fair Price | (93.76) - (125.02) | (116.81) |
| Upside | -145.1% - -160.1% | -156.2% |
| Date | P/E |
| 2024-10-10 | -25.95 |
| 2024-10-09 | -25.73 |
| 2024-10-08 | -25.70 |
| 2024-10-07 | -25.68 |
| 2024-10-04 | -25.78 |
| 2024-10-03 | -25.75 |
| 2024-10-02 | -25.73 |
| 2024-10-01 | -25.80 |
| 2024-09-30 | -25.80 |
| 2024-09-27 | -25.73 |
| 2024-09-26 | -25.75 |
| 2024-09-25 | -25.75 |
| 2024-09-24 | -25.73 |
| 2024-09-23 | -25.78 |
| 2024-09-20 | -25.75 |
| 2024-09-19 | -25.73 |
| 2024-09-18 | -25.73 |
| 2024-09-17 | -25.73 |
| 2024-09-16 | -25.75 |
| 2024-09-13 | -25.73 |
| 2024-09-12 | -25.88 |
| 2024-09-11 | -25.90 |
| 2024-09-10 | -25.88 |
| 2024-09-09 | -25.90 |
| 2024-09-06 | -25.88 |
| 2024-09-05 | -25.85 |
| 2024-09-04 | -25.85 |
| 2024-09-03 | -25.88 |
| 2024-09-02 | -25.90 |